PFKFB4 and glioblastoma: The overexpression of PFKFB4 was found to be associated with a poor prognosis in gastric cancer [58], bladder cancer [59], colon cancer [60], acute monocytic leukaemia [61], glioblastoma [62], thyroid cancer [63], and breast cancers [64–66].